Carregant...
Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitors
Histone deacetylases (HDACs) are promising drug targets for treating cancer, neurologic, inflammatory and metabolic diseases. Four small molecule inhibitors of HDACs have gained regulatory approval for treating lymphomas and multiple myelomas. Highly sensitive in vitro and cell-based profiling techn...
Guardat en:
| Publicat a: | Drug Discov Today Technol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4698312/ https://ncbi.nlm.nih.gov/pubmed/26723889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ddtec.2015.10.006 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|